Beijing Sun-Novo Pharmaceutical Research Co., Ltd. - PE Ratio

The PE Ratio as of August 2026 (TTM) for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) is 38.94

According to Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 38.94. This represents a change of -25.08% compared to the average of 51.97 of the last 4 quarters.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Historical PE Ratio (quarterly & annually)

How has 688621.SS PE Ratio performed in the past?

The mean historical PE Ratio of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. over the last ten years is 537.41. The current 38.94 PE Ratio has changed 624.59% with respect to the historical average. Over the past ten years (40 quarters), 688621.SS's PE Ratio was at its highest in in the September 2020 quarter at 178.71. The PE Ratio was at its lowest in in the December 2024 quarter at -34.91.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Average PE Ratio

How has 688621.SS PE Ratio performed in the past?

The current PE Ratio of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) PE Ratio vs. Peers

How is 688621.SS’s PE Ratio compared to its peers?

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s PE Ratio is less than Zhejiang Yatai Pharmaceutical Co., Ltd. (45.23), greater than Jinghua Pharmaceutical Group Co., Ltd. (25.99), greater than Shenzhen Weiguang Biological Products Co., Ltd. (20.42), greater than Shanghai Kaibao Pharmaceutical CO.,Ltd (25.07), greater than ChengDu ShengNuo Biotec Co.,Ltd. (23.00), greater than Jianmin Pharmaceutical Group Co.,Ltd. (13.55), greater than Jiangsu Jibeier Pharmaceutical Co., Ltd. (20.89), greater than Hunan Warrant Pharmaceutical Co.,Ltd (26.76), greater than Beijing Science Sun Pharmaceutical Co., Ltd. (-242.93), greater than Shenzhen Neptunus Bioengineering Co., Ltd. (-8.04),

Build a custom stock screener for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing Sun-Novo Pharmaceutical Research Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beijing Sun-Novo Pharmaceutical Research Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.